The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Presentation information

Poster Presentation

(E) Pharmaceutical Health Care and Sciences

[27PO7-am1] Regulatory sciences (pharmaceuticals, etc.)-2

Sun. Mar 27, 2022 9:00 AM - 10:40 AM [Room PO7] Bldgs. 3&4, 3F Passage (Bldgs. 3&4: 3F)

9:00 AM - 10:40 AM

[27PO7-am1-02] Clinical studies of insulin analogue and adalimumab, which have been approved by the FDA as “interchangeable products”

○Tetsu Kobayashi1, Hiroko Shibata1, Akiko Ishii1 (1. NIHS)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password